+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immune Disorders Drugs Market Research Reports

Graves Diseases Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Graves Diseases Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 36 Pages
  • Global
From
Gouty Arthritis (Gout) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Gouty Arthritis (Gout) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 133 Pages
  • Global
From
Psoriatic Arthritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Psoriatic Arthritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 182 Pages
  • Global
From
Systemic Mastocytosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Systemic Mastocytosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 53 Pages
  • Global
From
Pemphigus Vulgaris Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Pemphigus Vulgaris Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 60 Pages
  • Global
From
Systemic Lupus Erythematosus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Systemic Lupus Erythematosus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 432 Pages
  • Global
From
Inclusion Body Myositis (IBM) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Inclusion Body Myositis (IBM) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 104 Pages
  • Global
From
Toll Like Receptor 9 Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Toll Like Receptor 9 Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 72 Pages
  • Global
From
Toll Like Receptor 2 Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Toll Like Receptor 2 Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 59 Pages
  • Global
From
Toll Like Receptor 5 Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Toll Like Receptor 5 Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 39 Pages
  • Global
From
Toll Like Receptor Family Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Toll Like Receptor Family Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 227 Pages
  • Global
From
Medicaments Containing Corticosteroid Hormones - Market Analysis, Forecast, Size, Trends and Insights - Product Thumbnail Image

Medicaments Containing Corticosteroid Hormones - Market Analysis, Forecast, Size, Trends and Insights

  • Report
  • February 2026
  • Global
From
China - Medicaments Containing Corticosteroid Hormones - Market Analysis, Forecast, Size, Trends and Insights - Product Thumbnail Image

China - Medicaments Containing Corticosteroid Hormones - Market Analysis, Forecast, Size, Trends and Insights

  • Report
  • February 2026
  • China
From
U.S. - Medicaments Containing Corticosteroid Hormones - Market Analysis, Forecast, Size, Trends and Insights - Product Thumbnail Image

U.S. - Medicaments Containing Corticosteroid Hormones - Market Analysis, Forecast, Size, Trends and Insights

  • Report
  • February 2026
  • United States
From
Northern America - Medicaments Containing Corticosteroid Hormones - Market Analysis, Forecast, Size, Trends and Insights - Product Thumbnail Image

Northern America - Medicaments Containing Corticosteroid Hormones - Market Analysis, Forecast, Size, Trends and Insights

  • Report
  • February 2026
  • North America
From
EU - Medicaments Containing Corticosteroid Hormones - Market Analysis, Forecast, Size, Trends and Insights - Product Thumbnail Image

EU - Medicaments Containing Corticosteroid Hormones - Market Analysis, Forecast, Size, Trends and Insights

  • Report
  • February 2026
  • Europe
From
Middle East - Medicaments Containing Corticosteroid Hormones - Market Analysis, Forecast, Size, Trends and Insights - Product Thumbnail Image

Middle East - Medicaments Containing Corticosteroid Hormones - Market Analysis, Forecast, Size, Trends and Insights

  • Report
  • February 2026
  • Middle East
From
Asia - Medicaments Containing Corticosteroid Hormones - Market Analysis, Forecast, Size, Trends and Insights - Product Thumbnail Image

Asia - Medicaments Containing Corticosteroid Hormones - Market Analysis, Forecast, Size, Trends and Insights

  • Report
  • February 2026
  • Asia Pacific
From
Eastern Europe - Medicaments Containing Corticosteroid Hormones - Market Analysis, Forecast, Size, Trends and Insights. Update: COVID-19 Impact - Product Thumbnail Image

Eastern Europe - Medicaments Containing Corticosteroid Hormones - Market Analysis, Forecast, Size, Trends and Insights. Update: COVID-19 Impact

  • Report
  • February 2026
  • Europe
From
Immune Globulin Subcutaneous Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Immune Globulin Subcutaneous Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • October 2024
  • 72 Pages
  • Global
From
Loading Indicator

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection. The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more